Back
EHRA Premium Access

The effectiveness and safety of non-vitamin K antagonist oral anticoagulants (NOACs) in patients with atrial fibrillation: a Belgian nationwide cohort study

Session: Atrial Fibrillation - Round 1 - Stroke - OAC
Topic: Oral Anticoagulation
Speaker: Mr M. Grymonprez (Ghent, BE)
Event: EHRA 2023

Congress Presentation

About the speaker

Mr Maxim Grymonprez

Ghent University, Ghent (Belgium)
0 follower

7 more presentations in this session

5 years incident stroke, heart failure, acute myocardial infarction, and death in patients having undergone atrial fibrillation ablation according to BMI

Speaker: Doctor J. Toennesen (Gentofte, DK)

Access
Abstract
Slides
Thumbnail

Statin use improves the outcomes in patients with atrial fibrillation: A population-based study

Speaker: Miss J. Huang (Hong Kong, HK)

Access
Abstract
Slides
Thumbnail

Morphology-Voltage-P-wave-duration (MVP) score to select patients for continuous atrial fibrillation screening to prevent stroke

Speaker: Doctor L. Xing (Copenhagen, DK)

Access
Abstract
Slides
Thumbnail

How good is time-in-therapeutic-range defined warfarin treatment compared to standard dose direct oral anticoagulants? Incidence of stroke in atrial fibrillation in a nationwide registry study.

Speaker: Doctor M. Lehto (Helsinki, FI)

Access
Abstract
Slides
Thumbnail

Racial differences in atrial fibrillation-related bleeding and mortality.

Speaker: Doctor K. Dongseon (Seoul, KR)

Access
Abstract
Slides
Thumbnail

Access the full session

Atrial Fibrillation - Round 1 - Stroke - OAC

Speakers: Mr M. Grymonprez, Doctor J. Toennesen, Miss J. Huang, Doctor L. Xing, Doctor M. Lehto...
Access
Thumbnail

About the event

Image

EHRA 2023

16 April - 18 April 2023

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb